Literature DB >> 18290860

Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study).

S W van den Berg1, E H J Jansen, M Kruijshoop, P K Beekhof, E Blaak, C J van der Kallen, M M van Greevenbroek, E J M Feskens.   

Abstract

AIMS: Paraoxonase 1 (PON1) is an antioxidant high-density lipoprotein-bound enzyme, which was recently found to be expressed in the islets of Langerhans. A substitution (Q/R) at position 192 results in enzymes with different activity. Oxidation has been implicated in the onset of diabetes, and it can be hypothesized that PON1 may have a protective effect on diabetes. Our aim was to compare PON1 activities and PON1 Q/R phenotypes in subjects with different degrees of glucose intolerance.
METHODS: We examined 566 members of the Cohort study of Diabetes and Atherosclerosis Maastricht (CoDAM), including subjects with normal glucose tolerance (NGT, n = 298), impaired glucose regulation (IGR, n = 128), newly diagnosed Type 2 diabetes (nDM, n = 78) and treated, that is to say known, Type 2 diabetes (kDM, n = 64). PON1 activity was measured in serum using paraoxon and diazoxon as substrates. The PON1 phenotype was determined using two-dimensional enzyme analysis.
RESULTS: The RR-phenotype was significantly more frequent in nDM compared with NGT subjects (14.1 vs. 6.0%, P = 0.05). Adjusted for the PON1 phenotype, subjects with nDM had significant lower PON1 activity towards paraoxon and diazoxon than subjects with NGT. Adjusted odds ratios comparing the RR-variant with the QQ-variant were 2.17 [95% confidence interval (CI): 0.90-5.24] for impaired glucose tolerance, 2.84 (95% CI: 1.03-7.83) for nDM, 2.13 (95% CI; 0.61-7.42) for kDM and 2.65 (95% CI: 1.10-6.40) for total diabetes mellitus.
CONCLUSIONS: An aberrant PON1 phenotype distribution and PON1 activity were observed in early diabetes. In addition, the higher state of oxidative stress may affect the future development of complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18290860     DOI: 10.1111/j.1464-5491.2007.02328.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  11 in total

Review 1.  The genetics of vascular complications in diabetes mellitus.

Authors:  Dan Farbstein; Andrew P Levy
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

Review 2.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

3.  Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea.

Authors:  A Carreras; S X Zhang; E Peris; Z Qiao; Y Wang; I Almendros; D Gozal
Journal:  Int J Obes (Lond)       Date:  2014-10-09       Impact factor: 5.095

4.  Screening and Functional Pathway Analysis of Pulmonary Genes Associated with Suppression of Allergic Airway Inflammation by Adipose Stem Cell-Derived Extracellular Vesicles.

Authors:  Sung-Dong Kim; Shin Ae Kang; Yong-Wan Kim; Hak Sun Yu; Kyu-Sup Cho; Hwan-Jung Roh
Journal:  Stem Cells Int       Date:  2020-06-27       Impact factor: 5.443

5.  PON1 status evaluation in patients with chronic arterial occlusion of lower limbs due to atherosclerosis obliterans.

Authors:  Magdalena P Kasprzak; Maria Iskra; Wacław Majewski; Magdalena Budzyń-Napierała; Bogna Gryszczyńska; Krzysztof Strzyżewski; Jakub Kasprzak
Journal:  Arch Med Sci       Date:  2014-12-22       Impact factor: 3.318

6.  The Relation between Eating Habits and Abdominal Fat, Anthropometry, PON1 and IL-6 Levels in Patients with Multiple Sclerosis.

Authors:  Eraci Drehmer; Jose Luis Platero; Sandra Carrera-Juliá; Mari Luz Moreno; Asta Tvarijonaviciute; Marí Ángeles Navarro; María Mar López-Rodríguez; Jose Enrique de la Rubia Ortí
Journal:  Nutrients       Date:  2020-03-11       Impact factor: 5.717

7.  Metabolic and Functional Improvements in a Patient with Charcot-Marie-Tooth Disease Type 2 after EGCG Administration: A Case Report.

Authors:  Antonio Bustos; Pablo Selvi Sabater; María Benlloch; Eraci Drehmer; María Mar López-Rodríguez; Felix Platero; Jose Luis Platero; Jesús Escribá-Alepuz; Jose Enrique de la Rubia Ortí
Journal:  Medicina (Kaunas)       Date:  2021-01-24       Impact factor: 2.430

8.  Long term stability of paraoxonase-1 and high-density lipoprotein in human serum.

Authors:  Piet K Beekhof; Maryana Gorshunska; Eugène H J M Jansen
Journal:  Lipids Health Dis       Date:  2012-05-14       Impact factor: 3.876

9.  The association between postload plasma glucose levels and 38-year mortality risk of coronary heart disease: the prospective NHLBI Twin Study.

Authors:  Jun Dai; Ruth E Krasnow; Lei Liu; Stephen G Sawada; Terry Reed
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

10.  Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes.

Authors:  Durdi Qujeq; Abdolkarim Mahrooz; Ahad Alizadeh; Parisa Masoumi; Saleh Annemohammadzadeh; Ruzbeh Boorank
Journal:  J Diabetes Metab Disord       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.